Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,300 | -4,850 | -14,830 | -8,520 | -7,740 |
| Depreciation Amortization | 660 | 330 | 2,420 | 2,090 | 1,540 |
| Other Working Capital | 1,620 | 1,040 | 360 | -860 | 2,280 |
| Other Operating Activity | 160 | 70 | 820 | 750 | 620 |
| Operating Cash Flow | $-6,860 | $-3,410 | $-11,230 | $-6,540 | $-3,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -80 | -310 | -140 | -110 |
| Investing Cash Flow | $-130 | $-80 | $-310 | $-140 | $-110 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 23,320 | 23,550 | 19,990 | 20,200 | 15,560 |
| Financing Cash Flow | $23,320 | $23,550 | $19,990 | $20,200 | $15,560 |
| Beginning Cash Position | 21,500 | 21,050 | 12,600 | 12,600 | 12,600 |
| End Cash Position | 37,830 | 41,110 | 21,050 | 26,110 | 24,750 |
| Net Cash Flow | $16,320 | $20,060 | $8,450 | $13,510 | $12,140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,860 | -3,410 | -11,230 | -6,540 | -3,300 |
| Free Cash Flow | -6,860 | -3,410 | -11,230 | -6,540 | -3,300 |